Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.
Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.
This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Therapy. This report contains market size and forecasts of Oligonucleotide Therapy in global, including the following market information:
Global Oligonucleotide Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Oligonucleotide Therapy market was valued at US$ 3784.6 million in 2022 and is projected to reach US$ 4807.5 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.
We surveyed the Oligonucleotide Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Oligonucleotide Therapy Market Segment Percentages, by Type, 2022 (%)
Antisense Oligonucleotide
Aptamer
Others
Global Oligonucleotide Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Oligonucleotide Therapy Market Segment Percentages, by Application, 2022 (%)
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others
Global Oligonucleotide Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Oligonucleotide Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oligonucleotide Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oligonucleotide Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alnylam Pharmaceuticals Inc.
Biogen
Dynavax Technologies Corp.
Merck and Co.
Miragen Therapeuutics Inc.
Sarepta Therapeutics Inc.
GlaxoSmithKline
Pfizer
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oligonucleotide Therapy, market overview.
Chapter 2: Global Oligonucleotide Therapy market size in revenue.
Chapter 3: Detailed analysis of Oligonucleotide Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oligonucleotide Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oligonucleotide Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oligonucleotide Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oligonucleotide Therapy Overall Market Size
2.1 Global Oligonucleotide Therapy Market Size: 2022 VS 2032
2.2 Global Oligonucleotide Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oligonucleotide Therapy Players in Global Market
3.2 Top Global Oligonucleotide Therapy Companies Ranked by Revenue
3.3 Global Oligonucleotide Therapy Revenue by Companies
3.4 Top 3 and Top 5 Oligonucleotide Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oligonucleotide Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oligonucleotide Therapy Players in Global Market
3.6.1 List of Global Tier 1 Oligonucleotide Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Oligonucleotide Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oligonucleotide Therapy Market Size Markets, 2022 & 2032
4.1.2 Antisense Oligonucleotide
4.1.3 Aptamer
4.1.4 Others
4.2 By Type - Global Oligonucleotide Therapy Revenue & Forecasts
4.2.1 By Type - Global Oligonucleotide Therapy Revenue, 2018-2023
4.2.2 By Type - Global Oligonucleotide Therapy Revenue, 2024-2032
4.2.3 By Type - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oligonucleotide Therapy Market Size, 2022 & 2032
5.1.2 Infectious Diseases
5.1.3 Oncology
5.1.4 Neurodegenerative Disorders
5.1.5 Cardiovascular Diseases
5.1.6 Kidney Diseases
5.1.7 Others
5.2 By Application - Global Oligonucleotide Therapy Revenue & Forecasts
5.2.1 By Application - Global Oligonucleotide Therapy Revenue, 2018-2023
5.2.2 By Application - Global Oligonucleotide Therapy Revenue, 2024-2032
5.2.3 By Application - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Oligonucleotide Therapy Market Size, 2022 & 2032
6.2 By Region - Global Oligonucleotide Therapy Revenue & Forecasts
6.2.1 By Region - Global Oligonucleotide Therapy Revenue, 2018-2023
6.2.2 By Region - Global Oligonucleotide Therapy Revenue, 2024-2032
6.2.3 By Region - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Oligonucleotide Therapy Revenue, 2018-2032
6.3.2 US Oligonucleotide Therapy Market Size, 2018-2032
6.3.3 Canada Oligonucleotide Therapy Market Size, 2018-2032
6.3.4 Mexico Oligonucleotide Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Oligonucleotide Therapy Revenue, 2018-2032
6.4.2 Germany Oligonucleotide Therapy Market Size, 2018-2032
6.4.3 France Oligonucleotide Therapy Market Size, 2018-2032
6.4.4 U.K. Oligonucleotide Therapy Market Size, 2018-2032
6.4.5 Italy Oligonucleotide Therapy Market Size, 2018-2032
6.4.6 Russia Oligonucleotide Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Oligonucleotide Therapy Market Size, 2018-2032
6.4.8 Benelux Oligonucleotide Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Oligonucleotide Therapy Revenue, 2018-2032
6.5.2 China Oligonucleotide Therapy Market Size, 2018-2032
6.5.3 Japan Oligonucleotide Therapy Market Size, 2018-2032
6.5.4 South Korea Oligonucleotide Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Oligonucleotide Therapy Market Size, 2018-2032
6.5.6 India Oligonucleotide Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Oligonucleotide Therapy Revenue, 2018-2032
6.6.2 Brazil Oligonucleotide Therapy Market Size, 2018-2032
6.6.3 Argentina Oligonucleotide Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oligonucleotide Therapy Revenue, 2018-2032
6.7.2 Turkey Oligonucleotide Therapy Market Size, 2018-2032
6.7.3 Israel Oligonucleotide Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Oligonucleotide Therapy Market Size, 2018-2032
6.7.5 UAE Oligonucleotide Therapy Market Size, 2018-2032
7 Oligonucleotide Therapy Companies Profiles
7.1 Alnylam Pharmaceuticals Inc.
7.1.1 Alnylam Pharmaceuticals Inc. Company Summary
7.1.2 Alnylam Pharmaceuticals Inc. Business Overview
7.1.3 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Major Product Offerings
7.1.4 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.1.5 Alnylam Pharmaceuticals Inc. Key News & Latest Developments
7.2 Biogen
7.2.1 Biogen Company Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Oligonucleotide Therapy Major Product Offerings
7.2.4 Biogen Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.2.5 Biogen Key News & Latest Developments
7.3 Dynavax Technologies Corp.
7.3.1 Dynavax Technologies Corp. Company Summary
7.3.2 Dynavax Technologies Corp. Business Overview
7.3.3 Dynavax Technologies Corp. Oligonucleotide Therapy Major Product Offerings
7.3.4 Dynavax Technologies Corp. Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.3.5 Dynavax Technologies Corp. Key News & Latest Developments
7.4 Merck and Co.
7.4.1 Merck and Co. Company Summary
7.4.2 Merck and Co. Business Overview
7.4.3 Merck and Co. Oligonucleotide Therapy Major Product Offerings
7.4.4 Merck and Co. Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.4.5 Merck and Co. Key News & Latest Developments
7.5 Miragen Therapeuutics Inc.
7.5.1 Miragen Therapeuutics Inc. Company Summary
7.5.2 Miragen Therapeuutics Inc. Business Overview
7.5.3 Miragen Therapeuutics Inc. Oligonucleotide Therapy Major Product Offerings
7.5.4 Miragen Therapeuutics Inc. Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.5.5 Miragen Therapeuutics Inc. Key News & Latest Developments
7.6 Sarepta Therapeutics Inc.
7.6.1 Sarepta Therapeutics Inc. Company Summary
7.6.2 Sarepta Therapeutics Inc. Business Overview
7.6.3 Sarepta Therapeutics Inc. Oligonucleotide Therapy Major Product Offerings
7.6.4 Sarepta Therapeutics Inc. Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.6.5 Sarepta Therapeutics Inc. Key News & Latest Developments
7.7 GlaxoSmithKline
7.7.1 GlaxoSmithKline Company Summary
7.7.2 GlaxoSmithKline Business Overview
7.7.3 GlaxoSmithKline Oligonucleotide Therapy Major Product Offerings
7.7.4 GlaxoSmithKline Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.7.5 GlaxoSmithKline Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oligonucleotide Therapy Major Product Offerings
7.8.4 Pfizer Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Gilead Sciences
7.9.1 Gilead Sciences Company Summary
7.9.2 Gilead Sciences Business Overview
7.9.3 Gilead Sciences Oligonucleotide Therapy Major Product Offerings
7.9.4 Gilead Sciences Oligonucleotide Therapy Revenue in Global Market (2018-2023)
7.9.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oligonucleotide Therapy Market Opportunities & Trends in Global Market
Table 2. Oligonucleotide Therapy Market Drivers in Global Market
Table 3. Oligonucleotide Therapy Market Restraints in Global Market
Table 4. Key Players of Oligonucleotide Therapy in Global Market
Table 5. Top Oligonucleotide Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oligonucleotide Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oligonucleotide Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oligonucleotide Therapy Product Type
Table 9. List of Global Tier 1 Oligonucleotide Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oligonucleotide Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oligonucleotide Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Oligonucleotide Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oligonucleotide Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Oligonucleotide Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Oligonucleotide Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oligonucleotide Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Oligonucleotide Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Oligonucleotide Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oligonucleotide Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oligonucleotide Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oligonucleotide Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oligonucleotide Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oligonucleotide Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oligonucleotide Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Alnylam Pharmaceuticals Inc. Company Summary
Table 31. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product Offerings
Table 32. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Alnylam Pharmaceuticals Inc. Key News & Latest Developments
Table 34. Biogen Company Summary
Table 35. Biogen Oligonucleotide Therapy Product Offerings
Table 36. Biogen Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Biogen Key News & Latest Developments
Table 38. Dynavax Technologies Corp. Company Summary
Table 39. Dynavax Technologies Corp. Oligonucleotide Therapy Product Offerings
Table 40. Dynavax Technologies Corp. Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Dynavax Technologies Corp. Key News & Latest Developments
Table 42. Merck and Co. Company Summary
Table 43. Merck and Co. Oligonucleotide Therapy Product Offerings
Table 44. Merck and Co. Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Merck and Co. Key News & Latest Developments
Table 46. Miragen Therapeuutics Inc. Company Summary
Table 47. Miragen Therapeuutics Inc. Oligonucleotide Therapy Product Offerings
Table 48. Miragen Therapeuutics Inc. Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Miragen Therapeuutics Inc. Key News & Latest Developments
Table 50. Sarepta Therapeutics Inc. Company Summary
Table 51. Sarepta Therapeutics Inc. Oligonucleotide Therapy Product Offerings
Table 52. Sarepta Therapeutics Inc. Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Sarepta Therapeutics Inc. Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Oligonucleotide Therapy Product Offerings
Table 56. GlaxoSmithKline Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Oligonucleotide Therapy Product Offerings
Table 60. Pfizer Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Gilead Sciences Company Summary
Table 63. Gilead Sciences Oligonucleotide Therapy Product Offerings
Table 64. Gilead Sciences Oligonucleotide Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Oligonucleotide Therapy Segment by Type in 2022
Figure 2. Oligonucleotide Therapy Segment by Application in 2022
Figure 3. Global Oligonucleotide Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oligonucleotide Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Oligonucleotide Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oligonucleotide Therapy Revenue in 2022
Figure 8. By Type - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Oligonucleotide Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Oligonucleotide Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 16. US Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 28. China Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Oligonucleotide Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Oligonucleotide Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Biogen Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Dynavax Technologies Corp. Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck and Co. Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Miragen Therapeuutics Inc. Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Sarepta Therapeutics Inc. Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GlaxoSmithKline Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Gilead Sciences Oligonucleotide Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
